Background A number of cost-effectiveness analysis of influenza vaccination have been
conducted to estimate value of influenza vaccines in elderly and health workers (HWs). This …

Background Historically, lack of data on cost-effectiveness of influenza vaccination has been
identified as a barrier to vaccine use in low-and middle-income countries. We conducted a …

Background Using country-specific surveillance data to describe influenza epidemic activity
could inform decisions on the timing of influenza vaccination. We analysed surveillance data …

Two-thirds of the world's population aged 60 years and over will reside in lower and middle
income countries (LMIC) by 2050. Many LMICs are experiencing rapid population ageing at …

Background: Coronavirus disease 2019 (COVID-19) has had a devastating impact globally,
with severe health and economic consequences. To prepare health systems to deal with the …

Objective: Influenza vaccine reduces the burden of seasonal influenza and related
complications. Potential vaccination barriers need to be identified to raise awareness and …

Background: Internationally, Mobile Stroke Unit (MSU) ambulances have changed pre-
hospital acute stroke care delivery. MSU clinical and cost-effectiveness studies are …

Background Pregnant women, healthcare workers (HW), and adults>= 60 years have shown
an increased vulnerability to seasonal influenza virus infections and/or complications. In …

Background Seasonal influenza vaccination is clinically important and reduces
hospitalization costs for pregnant women. However, is it also a cost-effective intervention …

Background Influenza accounts for a substantial number of deaths and hospitalisations
annually in South Africa. To address this disease burden, the South African National …